share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora

Benzinga Real-time News ·  02/18 01:10

According to Coherent Market Insights, the global cannabis extract market is estimated to be valued at $10.74 billion in 2022 and is expected to exhibit a CAGR of 17.3% over the forecast period (2022-2030).

Key Trends And Analysis

The key players operating in the market are focusing on formulating new product offerings infused with CBD oil to provide consumers with easy access. For instance, in February 2020, Colgate-Palmolive Company (NYSE:CL), an American brand principally used for oral hygiene products, acquired Hello Product, LLC, a company that provides personal care products, and launched a series of CBD  oral care brands.

Furthermore, key players operating in the global cannabis extract market are focusing on adoption of inorganic growth strategies such as acquisitions to increase their market presence in the global market. For instance, in August 2019, Exactus, Inc. (OTC:EXDI), manufacturer of hemp-derived phytocannabinoid products, acquired Green Goddess Extracts, a contract manufacturer and formulator of hemp and vape products based in Florida, U.S. The acquisition will help expand Exactus, Inc.'s manufacturing capabilities.

Key Market Takeaways

The global cannabis extract market is expected to exhibit a CAGR of 17.3% during the forecast period, owing to the increasing product approvals and launches. For instance, in June 2019, Pure CBD Factory, an online pharmacy for cannabis medical products, announced the launch of Hemp CBD Oil Tinctures, available in three sizes as well as in the form of a topical cream used to help to ease pain.

Key players operating in the global cannabis extract market include Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis Inc. (NASDAQ:ACB), Tikun Olam (TASE:TKUN), Cannabis Science Inc., Maricann Group Inc., Tilray Inc. (NASDAQ:TLRY), VIVO Cannabis Inc. (OTCQX:VVCIF), Medical Marijuana, Inc. (OTCPK:MJNA), STENOCARE, Cronos Group Inc. (NASDAQ:CRON), MedMen (OTCQX:MMNFF), Teva Pharmaceutical Industries Ltd.(NYSE:TEVA), and Organigram Holdings Inc. (NASDAQ:OGI).

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.